Page last updated: 2024-08-23

piperacillin and cefotaxime

piperacillin has been researched along with cefotaxime in 248 studies

Research

Studies (248)

TimeframeStudies, this research(%)All Research%
pre-199069 (27.82)18.7374
1990's33 (13.31)18.2507
2000's89 (35.89)29.6817
2010's46 (18.55)24.3611
2020's11 (4.44)2.80

Authors

AuthorsStudies
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M1
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Cattoir, V; Nordmann, P; Poirel, L; Soares, A; Soussy, CJ1
Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A1
Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O1
Aubert, D; Naas, T; Nordmann, P; Ozcan, A1
Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV1
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A1
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M1
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM1
Kwon, DH; Lu, CD1
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A1
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C1
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S1
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R1
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F1
Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM1
Girlich, D; Leclercq, R; Naas, T; Nordmann, P1
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J1
Bonnet, R; Neuwirth, C; Robin, F; Siebor, E1
Cuzon, G; Demachy, MC; Naas, T; Nordmann, P1
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B1
Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC1
Amicosante, G; Celenza, G; De Santis, F; Forcella, C; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S1
Avison, MB; Okazaki, A1
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D1
Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV1
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z1
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ1
Bonnet, R; Caniça, M; Manageiro, V; Mendonça, N1
Cai, JC; Chen, GX; Zhang, R; Zhou, HW1
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L1
Lombardo, F; Obach, RS; Waters, NJ1
Docquier, JD; Frère, JM; Rossolini, GM; Stoczko, M1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Bauernfeind, A; Keuleyan, E; Markovska, R; Queenan, AM; Rasshofer, R; Schneider, I1
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR1
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N1
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL1
Cattoir, V; Nordmann, P; Poirel, L1
Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P1
Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C1
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N1
Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q1
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J1
Bonnet, R; Delmas, J; Pradel, N; Santini, CL; Wu, LF1
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N1
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C1
Galleni, M; Mammeri, H; Nordmann, P1
Asensi, MD; Gales, AC; Monteiro, J; Peirano, G; Santos, AF1
Goering, RV; Hanson, ND; Kurpiel, PM; Palepou, MF; Wolter, DJ; Woodford, N1
Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J1
Bradford, PA; Jones, CH; Petersen, PJ; Ruzin, A; Tuckman, M; Visalli, MA1
Denapaite, D; Hakenbeck, R; Zerfass, I1
Nordmann, P; Plésiat, P; Poirel, L; Rodriguez-Martinez, JM1
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS; Whichard, JM; Zioga, A1
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD1
Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M1
Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A1
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM1
Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX1
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A1
Adams-Haduch, JM; Bonomo, RA; Doi, Y; Endimiani, A; O'Keefe, A; Paterson, DL; Sidjabat, HE1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL1
Arlet, G; Bakour, R; Dallenne, C; Geneste, D; Iabadene, H; Messai, Y1
Giakkoupi, P; Miriagou, V; Papagiannitsis, CC; Pappa, O; Polemis, M; Tzouvelekis, LS; Vatopoulos, AC; Zioga, A1
Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U1
Bauernfeind, A; Keuleyan, E; Markova, B; Markovska, R; Queenan, AM; Schneider, I1
De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B1
Boyd, DA; Mulvey, MR1
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N1
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D1
Higgins, PG; Lehmann, M; Nordmann, P; Poirel, L; Seifert, H1
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K1
Girlich, D; Nordmann, P; Poirel, L3
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX1
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A1
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F1
Fortineau, N; Nordmann, P; Poirel, L; Rodriguez-Martinez, JM1
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M1
Bethel, C; Bonomo, RA; Choudhary, Y; Endimiani, A1
De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM1
Albuquerque, L; Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V1
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH1
Eb, F; Guillon, H; Mammeri, H1
Al Naiemi, N; Debets-Ossenkopp, YJ; Nordmann, P; Poirel, L; Rodríguez-Martínez, JM1
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M1
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ1
Bini, L; Bonomo, RA; Borgianni, L; Docquier, JD; Frère, JM; Matagne, A; Rossolini, GM; Vandenameele, J1
Bent, ZW; Young, GM1
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E1
Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S1
Harada, S; Ishii, Y; Saga, T; Tateda, K; Yamaguchi, K1
Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP1
Carattoli, A; García-Fernández, A; Giordano, A; Mancini, C; Miriagou, V; Papagiannitsis, CC; Venditti, M1
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS1
Lagrutta, E; Nordmann, P; Pham, J; Poirel, L; Taylor, P1
Bae, IK; Jeong, SH; Kim, J; Lee, K; Suh, B; Yong, D1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Pulse, ME; Weiss, WJ1
Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G1
Anderson, KC; Kellogg, GE; Sarkar, A1
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D1
Crenier, L; Gratia, JP1
Dubreuil, L; Sedallian, A1
Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S1
Bauernfeind, A; Grimm, H; Klietmann, W; Opferkuch, W; Werner, H1
Barrett, MS; Erwin, ME; Johnson, DM; Jones, RN1
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O1
Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A1
Heizmann, WR; Manncke, K; Sonntag, HG; Springsklee, M1
Neu, HC; Yu, KW1
Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M1
Marone, P; Monzillo, V; Navarra, A; Traverso, A1
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C1
Schmalreck, AF; Wildfeuer, A1
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD1
Allerberger, F; Bonatti, H; Dierich, MP; Guggenbichler, JP; Semenitz, E1
Huovinen, P; Huovinen, S; Katila, ML; Klossner, ML1
Allerberger, F; Ausserer, B; Fink, FM; Frischhut-Schiffer, EM; Guggenbichler, JP1
Eibel, G; Pfaff, G; Räder, K; Schmalreck, A; Wildfeuer, A1
Bartmann, K; Tarbuc, R1
Avril, JL; Donnio, PY; Lebert, P; Travert, MF1
Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C1
Donato, JB; Joseph, WS; LeFrock, JL; McCloskey, RV; Smith, BR; Weber, SJ1
Brorson, JE; Larsson, P1
Andersen, GE; Colding, H; Goldstein, K1
Aoki, A; Gato, S; Saigusa, M; Shiritani, Y; Tsuji, A; Yamaji, S; Yokoiyama, S1
Clausz, JC; Condon, RE; Edmiston, CE; Krepel, CJ1
Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G1
Munro, R; Rawlinson, W; Sorrell, T1
Arione, R; Di Nola, F; Marietti, G1
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W; van der Waaij, D1
Balfour, TW; Bourke, JB; Elliott, J; MacShane, L1
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K1
Howell, AW; Jorgensen, JH; Redding, JS1
Amato, G; Anzivino, D; Bolletti-Censi, M; Covelli, I; Fortunato, A; Guarino, A; Gulletta, E; Lavitola, A; Nani, E; Spagnoletti, G1
Chin, NX; Labthavikul, P; Neu, HC2
Falcidia, A; Mirone, L; Salvo, S1
Chin, NX; Labthavikul, P; Neu, HC; Saha, G1
Ashton, JJ; Brandt, JT; Copelan, EA; Fass, RJ; Moeschberger, ML1
Cowles, LS; Johnson, JD; Raff, MJ; Reid, KH; Shields, CB1
Cooper, CE; Griffin, KE; Slocombe, B; White, AR1
Malottke, R; Potel, J1
Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W1
Brom, A; Eckert, P; Schneider, G1
Hayakawa, T; Kishimoto, A; Suzuki, K; Yamamoto, K; Yamamoto, T1
Del Piero, E; Leopold, I; Pennett, M1
Childs, SJ; Mirelman, S; Wells, G1
Grassi, C1
Catovsky, D; Cohen, J; Darrell, JH; Donnelly, JP; Galton, DA; Goldman, JM; Marcus, RE; Want, SV; Worsley, AM1
Hoogkamp-Korstanje, JA1
De Leo, C; Eftimiadi, C; Schito, GC1
Fass, RJ; Helsel, VL1
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W2
Carret, G; Flandrois, JP1
Bruch, HP; Döll, W; Kujath, P; Schmidt, E1
Rahman, M1
Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS1
Cherubin, CE; Corrado, ML; Landesman, SH1
McCloskey, RV; Trent, JA; Tutlane, VA1
LeFrock, JL; Miller, MA; Vercler, MJ1
Häfelein, J; Marklein, G1
Marklein, G1
Daschner, FD; Kluge, D; Niederdellmann, H; Reibetanz, I; Silbermann, M1
Weinstein, AJ1
Braveny, I; Elsser, R; Machka, K1
Neu, HC; Prince, AS1
Traub, WH1
Ernest, KD; Magnussen, CR; Sammartino, MT1
Milatović, D1
Hoogkamp-Korstanje, JA; Meijer, CA1
Neu, HC2
Asphaug Kjellevold, V; Dibb, WL; Digranes, A1
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G1
Braveny, I; Machka, K1
Dietz, R; Machka, K1
Gianfrilli, P; Luzzi, I; Panichi, G; Pantosti, A1
Clarke, AM; Zemcov, SJ1
Monteil, H; Peladan, F; Zinsius, M1
Pohlod, DJ; Saravolatz, LD1
Calderwood, SB; Jackson, E; Tung, CC1
Hakenbeck, R1
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F1
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL1
Gasc, AM; Guenzi, E; Hakenbeck, R; Sicard, MA1
Bion, JF; Crosby, HA; Elliott, TS; Penn, CW1
Georgieff, M; Konrad, F; Neumeister, B; Rommel, H; Wagner, R1
O'Hara, K; Parker, CE; Perkins, JR; Shida, Y; Tomer, KB1
Grebe, T; Guenzi, E; Hakenbeck, R; König, A; Krauss, J; Reichmann, P1
Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M1
Grebe, T; Hakenbeck, R1
Aldridge, KE; Johnson, WD1
Fernández-Roblas, R; Gadea, I; García-Corbeira, P; Ponte, C; Soriano, F1
Grebe, T; Hakenbeck, R; Krauss, J; van der Linden, M1
Hanberger, H; Nilsson, LE1
Libby, JM1
Verbist, L; Verhaegen, J1
Corrado, OJ; Fawley, WN; Hawkey, PM; Settle, CD; Wilcox, MH1
Ell, C; Gossner, L; Hahn, EG; Keymling, J1
Abe, S; Ikeda, T; Suegara, N; Yamaguchi, H1
Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P1
Kitazato, M; Minami, S; Mitsuyama, J; Mizunaga, S; Morikawa, Y; Watanabe, Y1
Brown, A; Corrado, O; Donaldson, K; Fawley, W; Freeman, J; MacKinlay, S; Wilcox, MH1
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M1
Abe, K; Kimura, T; Moriya, M; Sakoda, S; Yamamoto, Y1
Kuroiwa, Y; Nakae, Y; Shimamura, M; Takahashi, T1
Blondel-Hill, E; Dobson, S; Paulus, S; Rassekh, S1
Qin, JP; Shi, WF; Zhou, J1
Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M1
Baquero, F; Cantón, R; Galán, JC; Novais, A; Ripoll, A; Rodríguez-Domínguez, MJ; Turrientes, MC1
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L1
Singh, HL; Singh, RM1
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D1
Becker, K; Bletz, S; Böking, T; Harmsen, D; Kipp, F; Mellmann, A; Prior, K; Schultes, A1
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B1
Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J1
Arnaud, A; Costet, N; Donnio, PY; Engrand, C; Habonimana, E; Nardi, N; Taleb, M; Tattevin, P; Wodey, E1
Alzari, PM; Bethel, CR; Bonomo, RA; Giannini, E; Klinke, S; Llarrull, LI; Mojica, MF; Otero, LH; Palacios, AR; Taracila, MA; Vila, AJ1
Jacqz-Aigrain, E; Leroux, S; Magréault, S; Storme, T; Touati, J1
Alagarsamy, S; Alharbi, NS; Alobaidi, AS; Chelliah, CK; Gnanasekaran, C; Govindan, R; Kadaikunnan, S; Manoharan, N; Muhammad Zubair, S1
Almind, SR; Andreasen, MR; Frimodt-Møller, N; Hansen, KH; Hertz, FB; Jelsbak, L; Nielsen, KL; Schønning, K1
Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T1
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T1
Babiak, P; Cizmarova, I; Kovac, A; Mikus, P; Parrak, V; Piestansky, J; Secnik, P1
Barclay, V; Beijer, G; Clarin, L; Eliasson, E; Östervall, J1
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z1
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y1
Béranger, A; Bille, E; Callot, D; Chouchana, L; Debray, A; Hirt, D; Oualha, M; Renolleau, S; Tréluyer, JM1
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I1
Abdulla, A; Bahmany, S; Ewoldt, TMJ; Koch, BCP1

Reviews

3 review(s) available for piperacillin and cefotaxime

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Respiratory infections: clinical evaluation.
    Clinical therapeutics, 1985, Volume: 7 Suppl A

    Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin

1985
The role of penicillin-binding proteins in penicillin resistance of Streptococcus pneumoniae.
    Developments in biological standardization, 1995, Volume: 85

    Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Genes, Bacterial; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Streptococcus pneumoniae

1995

Trials

13 trial(s) available for piperacillin and cefotaxime

ArticleYear
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies

1991
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin

1991
[Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
    Medizinische Klinik (Munich, Germany : 1983), 1991, Sep-15, Volume: 86, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mezlocillin; Middle Aged; Piperacillin; Sulbactam

1991
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies

1988
Cefotaxime plus metronidazole appears more effective than piperacillin in the prevention of postappendicectomy wound sepsis. Preliminary results of a comparative trial.
    Drugs, 1988, Volume: 35 Suppl 2

    Topics: Administration, Rectal; Adolescent; Adult; Aged; Appendectomy; Cefotaxime; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Piperacillin; Random Allocation; Suppositories; Surgical Wound Infection

1988
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:3 Pt 1

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation

1987
Role of piperacillin in surgical prophylaxis of genitourinary infections.
    Urology, 1985, Volume: 26, Issue:1 Suppl

    Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Female; Humans; Male; Piperacillin; Premedication; Surgical Wound Infection; Urinary Tract Infections; Urogenital System

1985
Ceftazidime as first-line therapy for fever in acute leukaemia.
    The Journal of infection, 1985, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Bacterial Infections; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Netilmicin; Neutropenia; Penicillin Resistance; Piperacillin; Random Allocation; Sepsis

1985
[Perioperative prophylaxis in elective colorectal surgery].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1984, Volume: 55, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Colonic Neoplasms; Combined Modality Therapy; Crohn Disease; Diverticulitis, Colonic; Humans; Intestinal Mucosa; Mezlocillin; Middle Aged; Moxalactam; Piperacillin; Premedication; Rectal Neoplasms; Surgical Wound Infection

1984
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A

    Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections

1983
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12

    Topics: Aged; beta-Lactamase Inhibitors; Cefotaxime; Clostridioides difficile; Cross Infection; Cross-Over Studies; Diarrhea; Drug Combinations; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Female; Humans; Male; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1998
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial.
    Endoscopy, 1999, Volume: 31, Issue:2

    Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Endoscopy; Enteral Nutrition; Enzyme Inhibitors; Female; Gastrostomy; Humans; Incidence; Intubation, Gastrointestinal; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Surgical Wound Infection; Tazobactam

1999
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:9

    Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2001

Other Studies

232 other study(ies) available for piperacillin and cefotaxime

ArticleYear
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis

1999
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Enterobacter cloacae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Plasmids; Quinolones; Sequence Alignment

2007
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids

2007
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation

2007
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data

2007
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2007
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA

2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests

2007
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2007
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA

2007
Polyamine effects on antibiotic susceptibility in bacteria.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus

2007
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome

2007
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland

2007
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA

2007
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins

2007
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet

2007
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2007
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid

2007
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity

2007
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam

2007
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity

2007
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids

2008
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity

2008
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia

2008
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Enterobacter aerogenes; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Sequence Analysis, DNA; Serratia marcescens; Structure-Activity Relationship; Substrate Specificity

2008
Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Enzyme Induction; Gene Expression Regulation, Bacterial; Genes, Regulator; Humans; Mutation; Stenotrophomonas maltophilia

2008
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA

2008
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States

2008
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin

2008
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary

2008
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Kinetics; Klebsiella pneumoniae

2008
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens

2008
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Molecular Sequence Data; Open Reading Frames; Pectobacterium carotovorum; Phenotype; Phylogeny; Recombinant Proteins; Sequence Homology, Amino Acid

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Bulgaria; Catalysis; Germany; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA

2008
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity

2008
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation

2008
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids

2008
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins

2008
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid

2008
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones

2008
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei

2009
Sec- and Tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Amoxicillin; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalothin; Escherichia coli; Escherichia coli Proteins; Green Fluorescent Proteins; Microbial Sensitivity Tests; Piperacillin; Protein Transport

2009
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia

2009
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence

2009
Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Asparagine; Bacterial Proteins; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Secondary; Serine

2009
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: beta-Lactamases; Brazil; Carbapenems; Klebsiella pneumoniae

2009
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Genetic Variation; Hydrolysis; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction

2009
Genetic variability among ampC genes from acinetobacter genomic species 3.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain

2009
Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Reproducibility of Results; Time Factors

2009
An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Binding Sites; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Point Mutation; Protein Binding; Streptococcus pneumoniae; Threonine; Transformation, Bacterial

2009
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; beta-Lactamases; Burkholderia cepacia complex; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Hydrolysis; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2009
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arginine; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Citrobacter freundii; Cysteine; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Glutamine; Humans; Hydrolysis; Inhibitory Concentration 50; Isoelectric Point; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Models, Molecular; Molecular Sequence Data; Plasmids; Salmonella enterica; Sequence Analysis, DNA; Species Specificity; Substrate Specificity; Transformation, Genetic

2009
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping

2009
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction

2009
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA

2009
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporinase; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA

2009
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping

2009
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed

2009
Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary

2009
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin

2009
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand

2009
Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Algeria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Piperacillin; Polymerase Chain Reaction; Proteus vulgaris; Providencia

2009
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Polymerase Chain Reaction

2009
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland

2009
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Bulgaria; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data

2009
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid

2009
TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolate.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11

    Topics: Base Sequence; beta-Lactamases; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data

2009
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom

2009
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2009
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Meropenem; Molecular Sequence Data; Oxacillin; Penicillins; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thienamycins

2009
Susceptibilities of 23 Desulfovibrio isolates from humans.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2009
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity

2010
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology

2010
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype

2010
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Protein Conformation; Reverse Transcriptase Polymerase Chain Reaction

2010
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA

2010
Spread of OXA-48-encoding plasmid in Turkey and beyond.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey

2010
In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2010
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic

2010
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology

2010
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Escherichia coli Proteins; Molecular Sequence Data

2010
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea

2010
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis

2010
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Integrons; Middle Aged; Molecular Sequence Data; Netherlands; Pseudomonas Infections; Pseudomonas stutzeri; Sequence Homology, Amino Acid; Substrate Specificity

2010
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam

2010
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests

2010
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; DNA Mutational Analysis; Enzyme Stability; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Protein Conformation; Protein Folding; Structure-Activity Relationship

2010
Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Microbial Sensitivity Tests; Polymerase Chain Reaction; Yersinia enterocolitica

2010
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed

2010
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa

2010
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: beta-Lactamases; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Klebsiella pneumoniae; Molecular Sequence Data; Polymerase Chain Reaction; Proteus mirabilis; Salmonella typhimurium

2010
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin

2010
An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Imipenem; Klebsiella pneumoniae; Meropenem; Molecular Sequence Data; Porins; Thienamycins

2010
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin

2010
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction

2010
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Reverse Transcriptase Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis

2011
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States

2011
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics

2012
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship

2013
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    European journal of medicinal chemistry, 2019, Apr-15, Volume: 168

    Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline

2019
Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolate SMG40 and its pigmented variant.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1992, Volume: 276, Issue:3

    Topics: Amoxicillin; Bacteriocins; Cefotaxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pigments, Biological; Piperacillin; Serratia marcescens

1992
[Strict anaerobic bacteria: comparative study of various beta-lactam antibiotics in combination with tazobactam or sulbactam].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Cefotaxime; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; In Vitro Techniques; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1991
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
    Infection, 1991, Volume: 19 Suppl 5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam

1991
[The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:8

    Topics: Acinetobacter; Bacteria; Bacteroides; Cefotaxime; Drug Interactions; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Sulbactam

1991
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:5

    Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas

1991
In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9

    Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Ceftazidime; Enterococcus faecalis; Erythromycin; Gentamicins; Haemophilus influenzae; Macrolides; Microbial Sensitivity Tests; Piperacillin; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes

1990
Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74

    Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Spheroplasts

1990
Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:12

    Topics: Bacteroides fragilis; Cefonicid; Cefotaxime; Cefotetan; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin

1990
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
    Pediatric hematology and oncology, 1990, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin

1990
In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:10

    Topics: Ampicillin; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Sulbactam

1990
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin

1989
[The kinetics of bacterial killing by fluctuating concentrations of antibiotics].
    Wiener klinische Wochenschrift, 1989, Mar-31, Volume: 101, Issue:7

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Cefotaxime; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli; Gentamicins; Piperacillin; Serratia marcescens; Staphylococcus aureus; Thienamycins

1989
Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli.
    Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; DNA Probes; Drug Resistance, Microbial; Gram-Negative Bacteria; Piperacillin; Plasmids

1989
[Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
    Padiatrie und Padologie, 1989, Volume: 24, Issue:1

    Topics: Adolescent; Agranulocytosis; Antineoplastic Agents; Cefamandole; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gentamicins; Humans; Infant; Infusion Pumps; Leukocyte Count; Male; Neoplasms; Neutropenia; Piperacillin; Sepsis

1989
Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefotaxime; Drug Synergism; Half-Life; Humans; Injections, Intravenous; Mezlocillin; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Sulbactam

1989
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
    Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology, 1985, Volume: 259, Issue:3

    Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines

1985
[Action of imipenem on Enterobacter cloacae].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Cefotaxime; Cefoxitin; Ceftazidime; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Imipenem; Moxalactam; Penicillin Resistance; Phenotype; Piperacillin; Thienamycins

1988
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins

1986
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa

1986
Sub MIC levels of cefoxitin and imipenem affect disc diffusion zone diameters to cefotaxime, ceftazidime, piperacillin and imipenem for Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2

    Topics: Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Ceftazidime; Drug Interactions; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins

1986
Stability of ampicillin, piperacillin, cefotaxime, netilmicin and amikacin in an L-amino acid solution prepared for total parenteral nutrition of newborn infants.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1988, Volume: 96, Issue:4

    Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Drug Stability; Electrolytes; Glucose; Humans; Infant, Newborn; Netilmicin; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Piperacillin; Solutions; Temperature; Time Factors

1988
[Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
    The Japanese journal of antibiotics, 1988, Volume: 41, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gentamicins; Male; Mice; Mice, Inbred ICR; Peritonitis; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections

1988
Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
    Diagnostic microbiology and infectious disease, 1988, Volume: 9, Issue:2

    Topics: Abdomen; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Cefotaxime; Cefotetan; Cefoxitin; Ceftizoxime; Cephamycins; Humans; Microbial Sensitivity Tests; Piperacillin

1988
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
    Australian and New Zealand journal of medicine, 1988, Volume: 18, Issue:6

    Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin

1988
[Changes in the phagocytic activity of human polymorphonuclear neutrophils induced in vitro by cefotiam vs 6 other antibiotics].
    Minerva medica, 1987, Jul-15, Volume: 78, Issue:13

    Topics: Adult; Cefoperazone; Cefotaxime; Cefotiam; Ceftazidime; Cephalosporins; Female; Gentamicins; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Phagocytosis; Piperacillin; Rifampin

1987
Antibiotic treatment, intestinal aerobic microflora and experimental sarcoma L-1 growth in Balb/c-mice.
    Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology, 1987, Volume: 265, Issue:3-4

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cell Division; Clindamycin; Enterobacteriaceae; Escherichia coli; Gentamicins; Intestines; Mezlocillin; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Piperacillin; Sarcoma, Experimental

1987
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
    Journal of clinical microbiology, 1986, Volume: 23, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin

1986
[Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Bollettino dell'Istituto sieroterapico milanese, 1986, Volume: 65, Issue:1

    Topics: Aztreonam; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Structure-Activity Relationship

1986
The in-vitro activity and beta-lactamase stability of carumonam.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Culture Media; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Piperacillin; Tobramycin

1986
[Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections].
    Minerva medica, 1987, Jan-31, Volume: 78, Issue:2

    Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Humans; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Urinary Tract Infections

1987
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:6

    Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin

1986
Platelet-mediated bleeding caused by broad-spectrum penicillins.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:6

    Topics: Adult; Bleeding Time; Blood Platelet Disorders; Cefotaxime; Hemorrhage; Humans; Mezlocillin; Penicillins; Piperacillin; Prospective Studies; Ticarcillin

1987
Effect of the topical application of some newer antibiotics on the cerebral cortex.
    Neurosurgery, 1987, Volume: 20, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cefoperazone; Cefotaxime; Cerebral Cortex; Metronidazole; Moxalactam; Piperacillin

1987
Temocillin. In vitro antibacterial activity.
    Drugs, 1985, Volume: 29 Suppl 5

    Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cefuroxime; Dose-Response Relationship, Drug; Drug Interactions; Enterobacteriaceae; In Vitro Techniques; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin

1985
Antibacterial activity of temocillin.
    Drugs, 1985, Volume: 29 Suppl 5

    Topics: Cefazolin; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin

1985
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
    Drugs, 1985, Volume: 29 Suppl 5

    Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin

1985
[Perioperative antibiotic prophylaxis. A comparative study of 244 patients with colonic diseases].
    Wiener medizinische Wochenschrift. Supplement, 1985, Volume: 87

    Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Colonic Diseases; Colonic Neoplasms; Female; Humans; Male; Metronidazole; Middle Aged; Piperacillin; Premedication; Risk; Surgical Wound Infection

1985
[Two cases of piperacillin-induced pneumonitis].
    Nihon Kyobu Shikkan Gakkai zasshi, 1985, Volume: 23, Issue:9

    Topics: Aged; Cefmenoxime; Cefotaxime; Humans; Male; Middle Aged; Piperacillin; Pneumonia; Radiography

1985
Pseudomonas cepacia endophthalmitis.
    Annals of ophthalmology, 1985, Volume: 17, Issue:12

    Topics: Aged; Cataract Extraction; Cefotaxime; Endophthalmitis; Gentamicins; Glaucoma; Humans; Iritis; Laser Therapy; Lenses, Intraocular; Male; Penicillin Resistance; Piperacillin; Pseudomonas; Pseudomonas Infections; Recurrence; Surgical Wound Infection; Trabecular Meshwork; Vitreous Body

1985
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:6

    Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin

1985
Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:3

    Topics: Ampicillin; Cefotaxime; Ceftriaxone; Drug Combinations; Drug Interactions; Escherichia coli; Humans; Infant, Newborn; Listeria monocytogenes; Meningitis; Microbial Sensitivity Tests; Penicillins; Piperacillin; Streptococcus agalactiae

1985
Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: Ampicillin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Humans; Methods; Microbial Sensitivity Tests; Penicillin G; Piperacillin; Pseudomonas aeruginosa; Sulbenicillin

1985
In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
    Diagnostic microbiology and infectious disease, 1986, Volume: 4, Issue:1

    Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Pseudomonas

1986
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
    Medical microbiology and immunology, 1985, Volume: 173, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin

1985
[Nonparametric approach to the determination of critical diameters. Comparison with conventional methods].
    Pathologie-biologie, 1984, Volume: 32, Issue:5 Pt 2

    Topics: Ampicillin; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Dibekacin; Escherichia coli; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus

1984
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor.
    Cancer immunology, immunotherapy : CII, 1984, Volume: 18, Issue:3

    Topics: Animals; Cefotaxime; Cell Line; Clindamycin; Cytotoxicity, Immunologic; Killer Cells, Natural; Lung Neoplasms; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin; Sarcoma, Experimental

1984
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
    Current medical research and opinion, 1984, Volume: 9, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin

1984
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:4

    Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa

1980
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:6

    Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa

1980
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:1

    Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity

1981
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Microbiology and immunology, 1981, Volume: 25, Issue:11

    Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens

1981
[In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1981, Volume: 251, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Doxycycline; Gentamicins; Listeria monocytogenes; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin

1981
[Chemotherapy of listeriosis (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1982, Mar-19, Volume: 107, Issue:11

    Topics: Ampicillin; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Doxycycline; Gentamicins; Humans; Listeriosis; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin

1982
Concentrations of cefotaxime and piperacillin in serum, subcutaneous tissue and muscle of patients undergoing dental surgery.
    Infection, 1981, Volume: 9, Issue:6

    Topics: Cefotaxime; Humans; Muscles; Penicillins; Piperacillin; Surgery, Oral

1981
The new cephalosporins and penicillins.
    Comprehensive therapy, 1982, Volume: 8, Issue:2

    Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin

1982
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Infection, 1982, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin

1982
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

1981
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Chemotherapy, 1982, Volume: 28, Issue:4

    Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa

1982
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin

1982
Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:2

    Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefotaxime; Cefotiam; Clindamycin; Doxycycline; Humans; Neutrophils; Penicillin G; Penicillins; Phagocytosis; Piperacillin; Staphylococcus aureus; Vancomycin

1982
In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa

1982
Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Azlocillin; Bacteria; Cefotaxime; Ceftizoxime; Drug Interactions; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas; Ticarcillin

1982
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Chemotherapy, 1983, Volume: 29, Issue:5

    Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin

1983
In vitro activity of HR 810, a new broad-spectrum cephalosporin.
    European journal of clinical microbiology, 1983, Volume: 2, Issue:4

    Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Humans; Neisseriaceae; Penicillin Resistance; Piperacillin; Staphylococcus aureus

1983
Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    European journal of clinical microbiology, 1983, Volume: 2, Issue:5

    Topics: Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa

1983
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Diagnostic microbiology and infectious disease, 1983, Volume: 1, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin

1983
Susceptibility of Bacteroides fragilis to cefotaxime and piperacillin: tentative interpretative standards for the disc-diffusion test.
    European journal of clinical microbiology, 1984, Volume: 3, Issue:1

    Topics: Bacteroides fragilis; Cefotaxime; Microbial Sensitivity Tests; Piperacillin

1984
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:2

    Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin

1984
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Presse medicale (Paris, France : 1983), 1984, Mar-29, Volume: 13, Issue:13

    Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens

1984
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin

1984
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
    Journal of clinical microbiology, 1984, Volume: 19, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin

1984
Target-mediated resistance to beta-lactam antibiotics.
    Biochemical pharmacology, 1995, Oct-12, Volume: 50, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Carrier Proteins; Cefotaxime; Hexosyltransferases; Molecular Sequence Data; Mosaicism; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Streptococcus pneumoniae

1995
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Pathologie-biologie, 1995, Volume: 43, Issue:4

    Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins

1995
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam

1995
A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae.
    Molecular microbiology, 1994, Volume: 12, Issue:3

    Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Cefotaxime; Chromosome Mapping; DNA Mutational Analysis; Drug Resistance, Microbial; Histidine Kinase; Molecular Sequence Data; Mutagenesis, Insertional; Mutation; Penicillin Resistance; Piperacillin; Protein Kinases; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Signal Transduction; Streptococcus pneumoniae

1994
Antibiotic-induced release of endotoxin from bacteria in vitro.
    Journal of medical microbiology, 1994, Volume: 40, Issue:1

    Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Endotoxins; Enterobacter cloacae; Escherichia coli; Humans; Limulus Test; Lipopolysaccharides; Microscopy, Electron, Scanning; Piperacillin; Silver Staining; Tobramycin

1994
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
    Intensive care medicine, 1993, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Respiration, Artificial; Staphylococcal Infections; Teicoplanin

1993
Nanoscale packed capillary liquid chromatography-electrospray ionization mass spectrometry: analysis of penicillins and cephems.
    Journal of chromatography, 1993, Jun-23, Volume: 616, Issue:1

    Topics: Cefotaxime; Cephalosporins; Cephamycins; Chromatography, Liquid; Humans; Mass Spectrometry; Penicillins; Piperacillin; Reference Standards

1993
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin

1996
Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4

    Topics: Amino Acid Sequence; Aminoacyltransferases; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactams; Carrier Proteins; Cefotaxime; Dose-Response Relationship, Drug; Hexosyltransferases; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Polymerase Chain Reaction; Streptococcus pneumoniae

1996
A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3

    Topics: Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactam Resistance; Cefotaxime; Cefoxitin; Ceftizoxime; Ceftriaxone; Cephalosporins; Clindamycin; Clostridium; Drug Resistance, Microbial; Eubacterium; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Piperacillin; Prevotella; Veillonella

1997
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal; Escherichia coli Infections; Male; Mice; Peritoneal Diseases; Piperacillin

1996
Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae.
    Microbial drug resistance (Larchmont, N.Y.), 1996,Summer, Volume: 2, Issue:2

    Topics: Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Polymerase Chain Reaction; Streptococcus pneumoniae; Transformation, Bacterial

1996
[A multicenter study shows alarming results. High antibiotic resistance within Swedish intensive care].
    Lakartidningen, 1997, Jun-18, Volume: 94, Issue:25

    Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Sweden

1997
Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Anti-Bacterial Agents; Biotransformation; Cefotaxime; Cephalosporins; Computer Systems; Escherichia coli; Microbial Sensitivity Tests; Penicillins; Piperacillin

1998
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae

1998
Efficacy of antibacterial drugs in mice with complex infection by Candida albicans and Escherichia coli.
    The Journal of antibiotics, 1999, Volume: 52, Issue:6

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Kanamycin; Kidney; Mice; Mice, Inbred ICR; Minocycline; Piperacillin; Tetracycline

1999
In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Ampicillin Resistance; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Hexosyltransferases; Humans; Kinetics; Meningitis, Haemophilus; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin

2004
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clostridioides difficile; Diarrhea; Drug Prescriptions; Drug Resistance; Drug Utilization; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Public Policy; Retrospective Studies; United Kingdom

2004
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Medycyna doswiadczalna i mikrobiologia, 2004, Volume: 56, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin

2004
Successful treatment of cervical spinal epidural abscess without surgery.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:10

    Topics: Cefotaxime; Cervical Vertebrae; Epidural Abscess; Humans; Male; Middle Aged; Piperacillin; Remission Induction

2005
[Recurrent bacterial meningitis in a case of Crouzon syndrome after craniofacial surgery].
    Rinsho shinkeigaku = Clinical neurology, 2007, Volume: 47, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Craniofacial Dysostosis; Drug Therapy, Combination; Ethmoid Sinusitis; Female; Humans; Meningitis, Bacterial; Piperacillin; Plastic Surgery Procedures; Postoperative Complications; Recurrence; Treatment Outcome

2007
In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefotaxime; Ceftazidime; Child; Drug Therapy, Combination; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Streptococcal Infections; Viridans Streptococci

2009
Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Chinese medical journal, 2009, May-05, Volume: 122, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Genotype; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin; Plasmids; Rifampin

2009
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
    The new microbiologica, 2009, Volume: 32, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins

2009
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Evolution, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Plasmids; Selection, Genetic; Tazobactam

2011
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate

2012
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Journal of infection in developing countries, 2014, Apr-15, Volume: 8, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests

2014
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays

2016
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:12

    Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Cross Infection; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Staphylococcal Infections; Vancomycin-Resistant Enterococci

2016
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2017
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:3

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins

2018
Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Cefotaxime; Child; Drug Therapy, Combination; Female; Gentamicins; Guideline Adherence; Humans; Length of Stay; Male; Metronidazole; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies

2018
The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Catalytic Domain; Cefepime; Cefotaxime; Ceftazidime; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Gene Expression; Genetic Vectors; Imipenem; Kinetics; Meropenem; Models, Molecular; Piperacillin; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Engineering; Protein Interaction Domains and Motifs; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity; Zinc

2019
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
    Journal of pharmaceutical and biomedical analysis, 2019, Sep-10, Volume: 174

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Limit of Detection; Male; Meropenem; Metronidazole; Pediatrics; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry

2019
Piperacillin/tazobactum and cefotaxime decrease the effect of beta lactamase production in multi-drug resistant K. pneumoniae.
    Journal of infection and public health, 2021, Volume: 14, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pharmaceutical Preparations; Piperacillin

2021
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model.
    International journal of antimicrobial agents, 2022, Volume: 59, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antigens, CD; beta-Lactamases; Cefotaxime; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Neoplasm Proteins; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2022
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin

2022
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
    Therapeutic drug monitoring, 2022, 12-01, Volume: 44, Issue:6

    Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Humans; Linezolid; Meropenem; Monobactams; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry; Tazobactam

2022
Reproducible Quantification of Unbound Fractions of Four Beta-Lactam Antibiotics: Ultrafiltration Versus Microdialysis of Spiked Healthy Donor Plasma.
    Therapeutic drug monitoring, 2023, 02-01, Volume: 45, Issue:1

    Topics: Anti-Bacterial Agents; Blood Proteins; Cefotaxime; Cloxacillin; Floxacillin; Humans; Microdialysis; Monobactams; Piperacillin; Ultrafiltration

2023
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
    Fish & shellfish immunology, 2022, Volume: 130

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence

2022
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study.
    European journal of pediatrics, 2023, Volume: 182, Issue:3

    Topics: Anti-Bacterial Agents; Bayes Theorem; beta-Lactams; Cefotaxime; Child; Critical Illness; Humans; Infusions, Intravenous; Meropenem; Piperacillin; Prospective Studies

2023
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
    Scientific reports, 2023, 01-09, Volume: 13, Issue:1

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing

2023
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions.
    Therapeutic drug monitoring, 2023, 10-01, Volume: 45, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Imipenem; Meropenem; Monobactams; Piperacillin; Tandem Mass Spectrometry

2023